| 摘要 |
A chemotheraputic cancer treatment in which Gö6976 or one of its derivatives is administered to a mammal for the treatment of the cancer. The Gö6976 or its derivative is directed to PKC alpha activity. Experiments have shown Gö6976 to be effective for the treatment of breast cancer, leukemia, lung cancer, bone cancer and skin cancer. These treatments may be accomplished utilizing Gö6976 or its derivatives alone or in combination with other prior art chemotherapy agents or in combination with radiation therapy. In a preferred embodiment Gö6976 is used for the treatment of cancer as a preventative drug by preventing cancer cell formation.
|
